Patents by Inventor Matej Sova

Matej Sova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9174930
    Abstract: The invention relates to the preparation of chiral compounds, in particular to the preparation of chiral compounds which may be used as intermediates for the preparation of anti-diabetic agents, preferably sitagliptin.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: November 3, 2015
    Assignee: LEK PHARMACEUTICALS D.D.
    Inventors: Matej Sova, Zdenko Casar, Gaj Stavber
  • Publication number: 20140213810
    Abstract: The invention relates to the preparation of chiral compounds, in particular to the preparation of chiral compounds which may be used as intermediates for the preparation of anti-diabetic agents, preferably sitagliptin.
    Type: Application
    Filed: April 6, 2012
    Publication date: July 31, 2014
    Applicant: LEK PHARMACEUTICALS D.D.
    Inventors: Matej Sova, Zdenko Casar, Gaj Stavber
  • Publication number: 20110183956
    Abstract: The present invention discloses novel and useful intermediates for the synthesis of ezetimibe (EZT), which intermediates share a characteristic Z-isomeric structure. Based on Z-5-(4-fluorophenyl)-pent-4-enoic acid, and proceeding the synthesis through further Z-intermediates, a total synthesis is presented to obtained final ezetimibe in high yields.
    Type: Application
    Filed: July 29, 2009
    Publication date: July 28, 2011
    Inventors: Janez Mravljak, Matej Sova, Andreja Kovac, Stanislav Gobec, Zdenko Casar